Spikemoss

Spikemoss contains bioactive biflavonoids including amentoflavone, robustaflavone, and hinokiflavone that demonstrate anticancer mechanisms in laboratory studies. These compounds induce apoptosis (programmed cell death) in cancer cells, inhibit tumor cell proliferation, and reduce inflammation through antioxidant activity. Caffeic acid contributes additional anti-inflammatory effects. Evidence level: C (preliminary research). Most data derives from in vitro and animal studies, with limited human clinical trials available.

Spikemoss may potentially interact with anticancer medications due to its effects on cellular pathways and drug-metabolizing enzymes. The biflavonoids could theoretically alter chemotherapy effectiveness or increase toxicity. Patients undergoing chemotherapy or radiation should consult their oncologist before using Spikemoss, as interactions have not been systematically studied. Evidence level: C. Always disclose all herbal supplements to your healthcare team during cancer treatment.

Traditional and contemporary herbal practice recommends 15-30 grams of dried Spikemoss herb daily, prepared as a decoction by boiling and simmering. Standardized extracts are typically taken at 500mg twice daily. Evidence level: C (traditional use and preliminary research). Dosage should be individualized under guidance of a qualified healthcare practitioner. Start with lower doses to assess tolerance and take with food to minimize digestive effects.

Spikemoss is contraindicated during pregnancy and breastfeeding. The herb contains bioactive biflavonoids that affect cellular processes, and insufficient safety data exists for these populations. Traditional use has not established safety for pregnant or nursing women. Women who are pregnant, trying to conceive, or breastfeeding should avoid Spikemoss entirely. Consult a qualified healthcare provider for appropriate alternatives during these periods.

Spikemoss (Selaginella doederleinii) has been used in Traditional Chinese Medicine and Southeast Asian medicine for centuries. Traditional applications include supporting cancer treatment, clearing heat conditions, reducing inflammation, and addressing infectious diseases. The herb is prepared as a decoction or taken as an extract. Evidence level: C. While traditional uses are well-documented, modern clinical evidence remains limited. Consult a qualified herbalist for appropriate therapeutic applications.

Spikemoss is generally well-tolerated at recommended doses. Reported side effects are primarily mild digestive effects, including stomach discomfort and nausea, particularly when taken on an empty stomach. Taking the herb with food may reduce these effects. Evidence level: C. Long-term safety data is limited. Discontinue use if adverse reactions occur and seek medical advice. Those with allergies to ferns or related plants should exercise caution.